Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci
Bodo Hoffmeister1, Johann Ockenga, Guido Schachschal
1Department of Internal Medicine and Infectious Diseases, Charité University Hospital, Schumannstrasse 20/21, 10117 Berlin, Germany. bodohoff@gmx.de
Abstract:
Secondary sclerosing cholangitis is a rare complication of acute bacterial cholangitis. The natural course of the disease is a slow progression over years. Here we report about a patient in whom sclerosing cholangitis evolved much faster as a consequence of a persistent biliary infection with vancomycin-resistant enterococci. The infection could be treated successfully with prolonged therapy with linezolid and teicoplanin. This is the first report of sclerosing cholangitis caused by vancomycin-resistant enterococci. It illustrates the rapidity with which this disease can evolve as a fulminant and ultimately fatal complication of acute bacterial cholangitis.
Related Concept Videos
Cholecystitis
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Bacterial Gastroenteritis
Development of Antibiotic Resistance
